A standardized mathematical reference and laboratory protocol for calculating fluid concentration and volumetric measurements when reconstituting 20 mg retatrutide research vials. Built specifically for bench scientists and analytical researchers evaluating multi-receptor agonist peptides in preclinical environments.
A standardized mathematical reference and laboratory protocol for calculating fluid concentration and volumetric measurements when reconstituting 20 mg retatrutide research vials. Built specifically for bench scientists and analytical researchers evaluating multi-receptor agonist peptides in preclinical environments.
To reconstitute a 20 mg retatrutide lyophilized vial, divide the total peptide mass (20,000 mcg) by your added diluent volume in milliliters. Adding 2.0 mL of bacteriostatic water yields a concentration of 10 mg/mL (100 mcg per U-100 insulin syringe mark). Adding 4.0 mL yields 5 mg/mL (50 mcg per unit), whereas 1.0 mL yields 20 mg/mL (200 mcg per unit).
Accurate volumetric dosing in laboratory settings depends on understanding the relationship between dry lyophilized peptide mass, added diluent volume, and resulting concentration. When using a 20 mg retatrutide vial, laboratory personnel must convert milligrams to micrograms to maintain precise micro-liter micro-dosing across experimental models. The fundamental formula for solution concentration is C = m / V, where C represents final concentration in mg/mL, m represents peptide mass in milligrams (20 mg), and V represents total diluent volume in milliliters.
When transferring reconstituted solution to standard laboratory micro-syringes—such as U-100 1.0 mL insulin syringes—the graduation marks represent hundredths of a milliliter (0.01 mL per unit). For a 20 mg retatrutide vial diluted with 2.0 mL of sterile bacteriostatic water, each individual unit mark delivers exactly 0.10 mg (100 mcg) of active compound. Utilizing a dedicated peptide calculator guide minimizes human calculation errors during fast-paced laboratory assays.
The table below outlines common diluent volumes paired with a 20 mg retatrutide vial and the resulting volumetric concentrations across standardized U-100 syringe units:
• 1.0 mL Diluent Volume: Yields 20.0 mg/mL concentration. 1 U-100 Unit (0.01 mL) = 0.20 mg (200 mcg). • 2.0 mL Diluent Volume: Yields 10.0 mg/mL concentration. 1 U-100 Unit (0.01 mL) = 0.10 mg (100 mcg). • 3.0 mL Diluent Volume: Yields 6.67 mg/mL concentration. 1 U-100 Unit (0.01 mL) = 0.0667 mg (66.7 mcg). • 4.0 mL Diluent Volume: Yields 5.0 mg/mL concentration. 1 U-100 Unit (0.01 mL) = 0.05 mg (50 mcg).
Selecting the appropriate diluent volume depends on your target concentration requirements for in vitro cellular exposure or in vivo rodent administration models. Researchers conducting high-concentration micro-injections often select lower diluent volumes (1.0–2.0 mL) to reduce fluid injection volumes, while broad titration protocols frequently employ 4.0 mL for finer volumetric accuracy per graduation unit.
Retatrutide (LY3437943) is a synthetic 39-amino-acid peptide engineered as a triple agonist targeting the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon (GCG) receptors. Its primary backbone incorporates amino acid modifications that impart high affinity across all three metabolic receptor targets while extending plasma half-life in preclinical animal models.
In comparative metabolic studies, researchers frequently evaluate retatrutide against dual and single receptor agonists such as tirzepatide, semaglutide, and non-incretin selective agents like cagrilintide. Preclinical data suggest that triple receptor engagement exhibits synergistic energetic effects, modulating both lipid oxidation via glucagon signaling and glucose homeostasis via GIP and GLP-1 signaling pathways simultaneously.
The choice of reconstitution fluid directly impacts compound stability, solubility, and contamination controls. For long-term multi-dose laboratory sampling over several weeks, sterile bacteriostatic water containing 0.9% benzyl alcohol is the standard diluent. The bacteriostatic agent inhibits bacterial proliferation during repeated septum punctures.
For acute in vitro cell culture assays or immediate single-use animal model administrations where benzyl alcohol may induce cellular toxicity, researchers utilize sterile 0.9% Sodium Chloride (Normal Saline) or Unpreserved Sterile Water for Injection. When using unpreserved diluents, any remaining reconstituted solution must be consumed immediately or discarded. For detailed diluent compatibility data, refer to our bacteriostatic water reconstitution protocol.
1. Disinfect the rubber stopper of the 20 mg retatrutide vial using an isopropyl alcohol wipe and allow it to air-dry completely under a laminar flow hood.
2. Using a sterile laboratory syringe, draw the exact pre-calculated volume of diluent (e.g., 2.0 mL of bacteriostatic water).
3. Equalize vial pressure if necessary, then insert the needle at a 45-degree angle through the center of the rubber stopper.
4. Direct the diluent stream against the glass side-wall of the vial rather than shooting fluid directly onto the lyophilized cake. Forceful direct stream impacts can break delicate peptide chains.
5. Allow the vacuum to pull the fluid in naturally if present; gently vent excess air pressure if resistance occurs.
6. Gently swirl the vial in a circular motion until the white cake is completely dissolved into a clear liquid solution. Never shake or agitate the vial vigorously, as shear forces cause denaturation and aggregation. For broader reconstitution guidance across diverse compounds, visit our retatrutide reconstitution guide.
Accurate reconstitution calculations depend on receiving vials containing precise peptide mass and uncompromised purity. Impurities or inaccurate fill weights distort liquid concentration calculations. PX1 Research adheres to rigorous US manufacturing and analytical testing protocols to guarantee lot-to-lot reliability.
Every batch of PX1 research peptides undergoes extensive verification in an ISO 17025 accredited laboratory:
• High-Performance Liquid Chromatography (RP-HPLC): Validates chemical purity levels exceeding 99%.
• Mass Spectrometry (MS): Confirms exact molecular weight and amino acid sequencing integrity.
• Endotoxin Testing (LAL Assay): Verifies endotoxin levels remain below strict preclinical research thresholds (<0.01 EU/mg).
• USA Manufacturing & Lot Traceability: Produced in GMP-compliant facilities with full batch documentation.
• Rapid Cold-Chain Handling: Orders ship same-day (Monday through Friday) from our CA and AZ distribution centers.
Explore our full catalog of verified compounds at all peptides or consult our PX1 research library for technical whitepapers.
Lyophilized 20 mg retatrutide powder should be stored long-term in a freezer at -20°C to -80°C, protected from moisture and light exposure. Under these ultra-low temperature conditions, unopened lyophilized vials remain stable for up to 24 months without significant structural degradation.
Once reconstituted with bacteriostatic water, the liquid solution must be stored under refrigeration at 2°C to 8°C (36°F to 46°F). Reconstituted retatrutide solutions should be utilized within 28 to 30 days. Avoid repeated freeze-thaw cycles of reconstituted solution, as phase changes degrade secondary structural stability. For bulk research projects or laboratory account orders, visit our wholesale portal.
How to use the 20 mg retatrutide reconstitution calculator?
To use the mathematical calculation formula, input your dry peptide mass (20 mg) and your desired diluent volume (e.g., 2 mL). The formula divides total milligrams by total volume to give your final concentration (10 mg/mL), allowing you to calculate individual micro-liter syringe units precisely for research applications.
How much bacteriostatic water should be added to 20 mg of retatrutide?
The volume of bacteriostatic water added depends on your desired research concentration. Common volumes are 2.0 mL (yielding 10 mg/mL) and 4.0 mL (yielding 5 mg/mL). Adding 2.0 mL makes mathematical unit calculations straightforward on U-100 syringes, where 1 unit equals 100 mcg.
What is the concentration of a 20 mg retatrutide vial mixed with 2 mL water?
Reconstituting a 20 mg retatrutide vial with 2.0 mL of bacteriostatic water yields a liquid concentration of exactly 10 mg/mL (10,000 mcg/mL). Each 0.01 mL graduation unit on a U-100 syringe contains 0.10 mg (100 mcg).
How many units on a U-100 syringe equals 1 mg of retatrutide if reconstituted with 2 mL?
When 20 mg of retatrutide is reconstituted with 2.0 mL of diluent (10 mg/mL concentration), 10 U-100 syringe units (0.10 mL) deliver exactly 1.0 mg (1,000 mcg) of research compound.
Can retatrutide be reconstituted with sterile saline instead of bacteriostatic water?
Yes. Sterile 0.9% Sodium Chloride (Normal Saline) can be used for acute, single-use laboratory assays. However, for multi-use vials accessed over multiple days, bacteriostatic water ( containing 0.9% benzyl alcohol) is required to prevent bacterial growth.
What happens if you shake the vial after adding diluent?
Vigorous shaking creates mechanical shear stress that can denature delicate peptide tertiary structures and lead to molecular aggregation. Always gently swirl the vial to dissolve the powder.
How long does reconstituted 20 mg retatrutide last in the refrigerator?
When reconstituted with sterile bacteriostatic water and stored at 2°C to 8°C, retatrutide maintains chemical stability for up to 30 days. Solutions reconstituted with unpreserved sterile water must be used immediately.
How do PX1 Research peptides ensure accurate fill weights for reconstitution?
PX1 Research validates lot mass integrity and chemical purity through RP-HPLC and mass spectrometry testing at an independent ISO 17025 accredited laboratory. A lot-specific Certificate of Analysis (COA) is provided with every batch.
What endotoxin standards apply to PX1 retatrutide research vials?
PX1 Research retatrutide undergoes rigorous Limulus Amebocyte Lysate (LAL) testing to ensure endotoxin levels remain below 0.01 EU/mg, preventing confounding inflammatory responses in sensitive preclinical assays.
Where does PX1 Research manufacture and ship retatrutide research vials?
All PX1 research compounds are manufactured in US-based GMP-compliant facilities and shipped directly from distribution hubs in California and Arizona with same-day shipping available Monday through Friday.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.